We finally identified PTBP1 in ACC, KIRP, and LGG; PTBP2 in ACC and KICH; and PTBP3 in ACC, LGG, and PAAD as potential prognostic biomarkers that may be involved in tumor progression in these tumor types. This evidence concerns the gene PTBP3 and pancreatic adenocarcinoma.